Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Handbook of Experimental Pharmacology|December 3, 2013
Arrestin-mediated activation of p38 MAPK: molecular mechanisms and behavioral consequencesCharles Chavkin, Selena S Schattauer, Jamie R Levin
Progress in Brain Research|September 4, 2007
Opioid systems in the dentate gyrusCarrie T Drake, Charles Chavkin, Teresa A Milner
The Journal of Biological Chemistry|June 20, 2003
Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalizationJay P McLaughlin, Mei Xu, Ken Mackie, et al.
Molecular Pain|January 30, 2010
Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in miceMegumi Aita, Margaret R Byers, Charles Chavkin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2014
Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbensJonathan M Ehrich, Paul E M Phillips, Charles Chavkin
Molecular Pharmacology|February 24, 2004
Distinct domains of the mu-opioid receptor control uncoupling and internalizationJeremy Celver, Mei Xu, Wenzhen Jin, et al.
The Journal of Comparative Neurology|November 15, 2008
Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleusB A S Reyes, Charles Chavkin, E J van Bockstaele
The Journal of Biological Chemistry|January 10, 2002
Conservation of the phosphate-sensitive elements in the arrestin family of proteinsJeremy Celver, Sergey A Vishnivetskiy, Charles Chavkin, et al.
Cellular Signalling|January 16, 2017
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptorSelena S Schattauer, Jamie R Kuhar, Allisa Song, et al.
Pageof 8